Unknown

Dataset Information

0

A CALM-derived nuclear export signal is essential for CALM-AF10-mediated leukemogenesis.


ABSTRACT: The t(10;11) chromosomal translocation gives rise to the CALM-AF10 fusion gene and is found in patients with aggressive and difficult-to-treat hematopoietic malignancies. CALM-AF10-driven leukemias are characterized by HOXA gene up-regulation and a global reduction in H3K79 methylation. DOT1L, the H3K79 methyltransferase, interacts with the octapeptide/leucine zipper domain of AF10, and this region has been shown to be necessary and sufficient for CALM-AF10-mediated transformation. However, the precise role of CALM in leukemogenesis remains unclear. Here, we show that CALM contains a nuclear export signal (NES) that mediates cytoplasmic localization of CALM-AF10 and is necessary for CALM-AF10-dependent transformation. Fusions of the CALM NES (NES(CALM)-AF10) or NES motifs from heterologous proteins (ABL1, Rev, PKIA, APC) in-frame with AF10 are sufficient to immortalize murine hematopoietic progenitors in vitro. The CALM NES is essential for CALM-AF10-dependent Hoxa gene up-regulation and aberrant H3K79 methylation, possibly by mislocalization of DOT1L. Finally, we observed that CALM-AF10 leukemia cells are selectively sensitive to inhibition of nuclear export by Leptomycin B. These findings uncover a novel mechanism of leukemogenesis mediated by the nuclear export pathway and support further investigation of the utility of nuclear export inhibitors as therapeutic agents for patients with CALM-AF10 leukemias.

SUBMITTER: Conway AE 

PROVIDER: S-EPMC3674674 | biostudies-literature | 2013 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

A CALM-derived nuclear export signal is essential for CALM-AF10-mediated leukemogenesis.

Conway Amanda E AE   Scotland Paula B PB   Lavau Catherine P CP   Wechsler Daniel S DS  

Blood 20130313 23


The t(10;11) chromosomal translocation gives rise to the CALM-AF10 fusion gene and is found in patients with aggressive and difficult-to-treat hematopoietic malignancies. CALM-AF10-driven leukemias are characterized by HOXA gene up-regulation and a global reduction in H3K79 methylation. DOT1L, the H3K79 methyltransferase, interacts with the octapeptide/leucine zipper domain of AF10, and this region has been shown to be necessary and sufficient for CALM-AF10-mediated transformation. However, the  ...[more]

Similar Datasets

| S-EPMC5527775 | biostudies-literature
| S-EPMC4261044 | biostudies-literature
2005-07-01 | GSE2117 | GEO
2017-06-19 | GSE58853 | GEO
| S-EPMC3932800 | biostudies-other
| S-EPMC2547126 | biostudies-literature
| S-EPMC2397317 | biostudies-literature
| S-EPMC2366104 | biostudies-literature
| S-EPMC4425349 | biostudies-literature
| S-EPMC5900708 | biostudies-literature